Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

55 results about "Mucor circinelloides" patented technology

Mucor circinelloides is a dimorphic fungus belonging to the Order Mucorales (Division Mucormycota). It has a worldwide distribution, found mostly in soil, dung and root vegetables. This species is described as not known to be able to produce mycotoxins, however it has been frequently reported to infect animals such as cattle and swine, as well as fowl, platypus and occasionally humans. Ketoacidotic patients are particularly at risk for infection by M. circinelloides.

Mucor circinelloides bacterial strain, cultivating method and application of the same in C21, C19 sterides and aza sterides biotransformation

The invention discloses a Mucor circinelloides lusitanicus AY234877 strain which has the stereoselective hydroxylase activity, which is collected in the China general microbiological culture collection center on November 20, 2007, the collection number is CGMCC.NO.2256, and the invention is characterized in that the positions of 6 Beta, 7 Alpha, 11 Alpha and 14 Alpha of C21 and C19 steroid substrates can be carried out a hydroxylation. The invention further discloses a method for preparing the 6 Beta, 7 Alpha, 11 Alpha and 14 Alpha hydroxylated derivatives of the C21 and C19 steroids and aza steroids. The method has simple operation, low cost and better yield and stereoselectivity; furthermore, the invention does not cause environmental pollution. The strain can carry out the hydroxylation reaction of the C21 and C19 steroids and aza steroid compounds which have the structural characteristics of 4-en-3-one or 5-en-3-ol, and the obtained hydroxylated derivatives are the important intermediates for the synthesis of a plurality of steroid compounds. Compared with the steroid hydroxylation chemical synthesis, the method can simplify drug synthetic steps, reduce pollution, reduce cost and have important application value for promoting the development process of the steroid drug intermediates of China.
Owner:ZHENGZHOU UNIV

Method for preparing laccase by using mucor circinelloides DK1 strain

The invention relates to a method for preparing laccase by using a mucor circinelloides DK1 strain. The method comprises the following steps: (1) transferring the mucor circinelloides DK1 strain from a PDA slant culture medium into a triangular flask filled with a basic liquid medium, carrying out shaking culture, filtering the fermentation liquor to obtain mycelium, washing the mycelium by using sterile water, scattering, collecting the mycelium in the sterile water to prepare mycelium suspension, and preserving the suspension for later use; (2) putting an enzyme production culture medium into the triangular flask, inoculating the mycelium suspension, carrying out shaking culture, periodically extracting the fermentation liquor in the culture process, centrifuging, and taking the supernatant, thereby obtaining the crude enzyme liquor; and (3) centrifuging the crude enzyme liquor, and taking the supernatant, thereby obtaining the laccase. The method disclosed by the invention is simple in process, is suitable for large-scale industrial production and the like, and the prepared laccase can effectively remove non-cellulose colloid in flax, jute, kenaf or bamboo fibers, has the advantages of high degumming efficiency, short degumming period, high fiber dispersion rate, high refined dried-jute quality and the like and has good application prospects.
Owner:DONGHUA UNIV

Construction method of mucor circinelloides cell factory for producing dihomo-gamma-linolenic acid and fermentation technology

The present disclosure relates to a construction method of a Mucor circinelloides cell factory for producing dihomo-γ-linolenic acid and a fermentation technology, belonging to the field of genetic engineering. In the present disclosure, γ-linolenic acid elongase gene glelo is obtained from Mortierella alpine by cloning, the gene is ligated to an integrative plasmid pMAT1552, and transformed into a Mucor circinelloides defective strain Mu402, and the gene glelo is integrated into Mucor circinelloides genome through homologous recombination, to obtain the recombinant strain Mc-glelo, and finally, the expression of the gene glelo in Mucor circinelloides is realized. The lipid content in the recombinant strain Mc-glelo is not obviously different from that in the control strain Mc1552, however, the lipid composition changes greatly, and dihomo-γ-linolenic acid appears in the lipids of the recombinant strain Mc-glelo, and the content thereof reaches 5.7% of the total fatty acids. Under optimized fermentation conditions and in the presence of precursor fatty acid, the DGLA content reaches 7.6%. The new recombinant strain was deposited in China General Microbiological Culture Collection Center on Jun. 20, 2018, with the address of No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing. The accession number given to the biological material by the collection center is CGMCC No. 15887, and the suggested taxonomic denomination is Mucor circinelloides-GLELO.
Owner:SHANDONG UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products